Free Trial

Kinaxis Inc. (TSE:KXS) Given Average Recommendation of "Moderate Buy" by Brokerages

Kinaxis logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst consensus: Kinaxis carries an average recommendation of "Moderate Buy" from seven analysts (six buy, one hold) with a mean 12‑month price target of C$208.67.
  • Several brokerages have recently trimmed targets to roughly C$180–C$200 (BMO to C$180; Scotiabank, TD, RBC and Canaccord around C$200), reflecting more cautious near‑term expectations.
  • Shares opened at C$143.27 (52‑week range C$117.22–C$212.45) while the company reports a high valuation (P/E 58.48) and recent quarter results of C$0.93 EPS on C$189.95M revenue.
  • Five stocks to consider instead of Kinaxis.

Kinaxis Inc. (TSE:KXS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the seven ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is C$208.67.

A number of brokerages recently issued reports on KXS. BMO Capital Markets cut their price objective on Kinaxis from C$225.00 to C$180.00 in a research report on Monday, March 2nd. Scotiabank decreased their target price on shares of Kinaxis from C$240.00 to C$200.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 4th. TD Securities lowered their target price on shares of Kinaxis from C$229.00 to C$200.00 and set a "buy" rating for the company in a research note on Friday, March 6th. Royal Bank Of Canada dropped their price target on shares of Kinaxis from C$235.00 to C$200.00 and set an "outperform" rating for the company in a research report on Monday, January 26th. Finally, Canaccord Genuity Group decreased their price objective on shares of Kinaxis from C$225.00 to C$200.00 in a report on Friday, March 6th.

Check Out Our Latest Stock Analysis on KXS

Kinaxis Stock Performance

Shares of Kinaxis stock opened at C$143.27 on Friday. The firm has a market capitalization of C$3.96 billion, a price-to-earnings ratio of 58.48, a PEG ratio of 3.60 and a beta of 0.76. Kinaxis has a fifty-two week low of C$117.22 and a fifty-two week high of C$212.45. The company has a debt-to-equity ratio of 11.39, a quick ratio of 2.29 and a current ratio of 1.97. The stock has a 50 day moving average of C$132.85 and a 200 day moving average of C$160.45.

Kinaxis (TSE:KXS - Get Free Report) last posted its earnings results on Wednesday, March 4th. The company reported C$0.93 EPS for the quarter. Kinaxis had a return on equity of 16.46% and a net margin of 12.90%.The company had revenue of C$189.95 million for the quarter. As a group, research analysts predict that Kinaxis will post 4.2526231 earnings per share for the current year.

About Kinaxis

(Get Free Report)

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation. Kinaxis's S&OP solution capabilities include supply and demand planning, capacity and inventory planning, and inventory management. The firm has operations in North America, Europe, and Asia-Pacific regions.

See Also

Analyst Recommendations for Kinaxis (TSE:KXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines